Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.30%139.68M | -0.37%130.98M | 6.43%135.51M | -3.37%551.44M | -9.82%143.59M | -13.66%149.07M | 3.23%131.46M | 14.23%127.32M | -19.73%570.68M | 0.72%159.22M |
| Cost of revenue | -5.41%100.55M | -3.97%93.47M | -4.76%97.56M | -8.27%401.42M | -21.82%95.36M | -15.12%106.29M | -2.99%97.34M | 13.68%102.43M | -13.47%437.63M | 0.23%121.98M |
| Gross profit | -8.52%39.13M | 9.90%37.5M | 52.45%37.95M | 12.76%150.02M | 29.48%48.23M | -9.80%42.78M | 26.32%34.13M | 16.55%24.89M | -35.15%133.05M | 2.36%37.25M |
| Operating expense | -3.18%11.38M | 15.34%11.59M | 16.39%12.57M | 9.16%49.72M | 20.41%17.23M | -11.67%11.75M | -1.14%10.05M | 39.05%10.8M | -31.68%45.55M | -0.42%14.31M |
| Selling and administrative expenses | -2.12%12.39M | 6.01%12.12M | 10.47%13.08M | 6.53%53.41M | 18.40%17.58M | -8.21%12.66M | 2.64%11.44M | 14.43%11.84M | -27.49%50.13M | -1.23%14.85M |
| -Selling and marketing expense | -6.01%8.1M | -6.27%7.2M | 17.26%8.56M | 6.27%33.44M | 15.59%9.85M | -8.38%8.62M | 8.71%7.68M | 12.60%7.3M | -33.82%31.47M | -3.44%8.52M |
| -General and administrative expense | 6.16%4.29M | 31.07%4.93M | -0.46%4.52M | 6.97%19.96M | 22.20%7.74M | -7.86%4.05M | -7.87%3.76M | 17.51%4.54M | -13.57%18.66M | 1.91%6.33M |
| Total other operating income | 11.55%1.01M | -61.73%530K | -50.96%511K | -19.58%3.69M | -34.88%351K | 85.51%909K | 42.05%1.39M | -59.63%1.04M | 85.09%4.59M | -18.72%539K |
| Operating profit | -10.54%27.76M | 7.63%25.91M | 80.08%25.38M | 14.64%100.31M | 35.14%31M | -9.08%31.03M | 42.90%24.08M | 3.70%14.09M | -36.83%87.5M | 4.18%22.94M |
| Net non-operating interest income (expenses) | 10.85%1.68M | 26.74%1.83M | 15.66%1.54M | 39.76%6.02M | 38.26%1.73M | 31.71%1.51M | 56.60%1.45M | 35.23%1.33M | 74.47%4.31M | 27.50%1.25M |
| Non-operating interest income | 13.08%1.82M | 29.59%1.98M | 20.54%1.68M | 38.59%6.39M | 40.62%1.86M | 33.50%1.61M | 49.85%1.52M | 31.05%1.4M | 42.59%4.61M | 25.84%1.32M |
| Non-operating interest expense | 48.94%140K | 83.12%141K | 114.49%148K | 21.89%368.42K | 82.86%128K | 70.91%94K | -17.20%77K | -17.86%69K | -60.42%302.26K | 2.05%70K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -112.77K | 0 | ||||||||
| Less:Write off | ---- | ---- | ---- | --112.77K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -25.16%6.91M | 0.88%9.01M | -62.79%4.07M | 516.17%18.16M | 6.34%-10.94M | 651.30%9.23M | 92.90%8.94M | 650.45%10.93M | 35.50%-4.36M | 1.74%-11.68M |
| Income before tax | -12.99%36.34M | 6.68%36.76M | 17.56%30.99M | 42.23%124.37M | 74.18%21.79M | 14.42%41.76M | 53.80%34.46M | 64.42%26.36M | -34.85%87.44M | 12.57%12.51M |
| Income tax | -52.67%4.99M | 11.84%9.55M | 14.30%8.1M | 39.41%31.49M | 43.12%5.34M | 13.80%10.53M | 51.01%8.54M | 79.34%7.08M | -38.74%22.59M | -36.76%3.73M |
| Net income | 0.38%31.35M | 4.98%27.21M | 18.76%22.89M | 43.20%92.88M | 87.37%16.45M | 14.63%31.23M | 54.74%25.92M | 59.54%19.27M | -33.37%64.85M | 68.35%8.78M |
| Net income continuous operations | 0.38%31.35M | 4.98%27.21M | 18.76%22.89M | 43.20%92.88M | 87.37%16.45M | 14.63%31.23M | 54.74%25.92M | 59.54%19.27M | -33.37%64.85M | 68.35%8.78M |
| Noncontrolling interests | 42.59%231K | 52.70%339K | 31.00%262K | 104.19%840.84K | 497.67%257K | 33.88%162K | 15.03%222K | 263.64%200K | -34.46%411.8K | -50.19%43K |
| Net income attributable to the company | 0.16%31.12M | 4.57%26.87M | 18.63%22.63M | 42.82%92.03M | 85.35%16.2M | 14.55%31.07M | 55.20%25.7M | 58.60%19.07M | -33.37%64.44M | 70.34%8.74M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 0.16%31.12M | 4.57%26.87M | 18.63%22.63M | 42.82%92.03M | 85.35%16.2M | 14.55%31.07M | 55.20%25.7M | 58.60%19.07M | -33.37%64.44M | 70.34%8.74M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.18%0.1115 | 4.56%0.0963 | 18.57%0.0811 | 42.77%0.3298 | 85.30%0.058 | 14.51%0.1113 | 55.31%0.0921 | 58.70%0.0684 | -33.35%0.231 | 70.11%0.0313 |
| Diluted earnings per share | 0.18%0.1115 | 4.56%0.0963 | 18.57%0.0811 | 42.77%0.3298 | 85.30%0.058 | 14.51%0.1113 | 55.31%0.0921 | 58.70%0.0684 | -33.35%0.231 | 70.26%0.0313 |
| Dividend per share | 0 | 0.00%0.05 | 0 | 100.00%0.2 | 200.00%0.15 | 0 | 0.00%0.05 | 0 | -50.00%0.1 | -50.00%0.05 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.